Table 2.
Electrochemical HPLC detection of BH4, BH2 and ascorbate in adult rat cardiomyocytes supplemented with ascorbate and BH4.
Treatment | BH4 (pmol/mg protein) | BH2 (pmol/mg protein) | Ascorbate (pmol/mg protein) |
---|---|---|---|
Control | 0.066±0.058 | 0.0 | 14.55±0.65 |
Asc/BH4 | 1.33±0.71a | 104.4±47.6 | 801.0±315.3a |
Asc/BH4 + LPS | 0.297±0.092b | 172.66±54.3 | 501.9±58.5 |
Asc/BH4 + TNF-α + IFN-γ | 0.609±0.138b | 196.0±21.8 | 814.0±124.2 |
Adult cardiomyocytes were pre-treated with ascorbate and BH4 for 6 hr before addition of LPS and cytokines for 12 hr. Conditions include: LPS (1μg/ml); TNF-α (20 ng/ml); IFN-γ (50 ng/ml); ascorbate (75 μM)/BH4 (10 μM). Values represent the mean±SD of at least 3 experiments.
P<0.01 vs control;
P<0.05 vs Asc/BH4.